Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes

Benedict E. Mc Larney, Qize Zhang, Edwin C. Pratt, Magdalena Skubal, Elizabeth Isaac, Hsiao-Ting Hsu, Anuja Ogirala and Jan Grimm
Journal of Nuclear Medicine January 2023, 64 (1) 177-182; DOI: https://doi.org/10.2967/jnumed.122.264079
Benedict E. Mc Larney
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qize Zhang
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin C. Pratt
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena Skubal
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Isaac
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsiao-Ting Hsu
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anuja Ogirala
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Grimm
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
3Pharmacology Program, Weill Cornell Medical College, New York, New York;
4Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and
5Department of Radiology, Weill Cornell Medical Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    SWIR CL radioisotope imaging setup and characterization. (A) A dark enclosure was used for all imaging. Mounted on the camera was a 16 or 8 mm ƒ/1.4 SWIR lens. (©2022 Memorial Sloan Kettering Cancer Center. All rights reserved.) (B) Linearity assessment of the camera via 68Ga imaged at positions (P1, P2) across the field of view, with P1 + cardboard confirming that detection was not as a result of γ strikes. (C) SWIR gray levels and corresponding 68Ga activity (MBq). Linear regression and 95% CIs are shown (Pearson R2 = 0.9839, 2-tailed P < 0.0001). SWIR CLI is linearly responsive and quantitative as found with VIS CLI. (D) 32P SWIR gray-value intensity in relation to exposure time changes. (E) Graphical representation of radioisotope (32P) SWIR CL emission spectrum from 900 to 1,500 nm, with the blue line representing a 1-phase exponential decay function (R2 = 0.9812). Inherent system noise, low photon production, and water absorption prevent detection > 1,400 nm. (F) Descending radioisotope radiance (32P, 68Ga, 89Zr, 18F, and 131I) corrected for concentration (kBq/μL) and spatial field of view (cm2). Student t test (unpaired, 2-sided) P values are shown. In all cases, mean measurements (red line), SDs (black lines), and individual measurements (n = 90 technical replicates, gray dots) are shown, for radiance comparison negative values were excluded.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Reduced scattering via SWIR CLI (900–1,700 nm) over VIS CLI (400–900 nm). (A) Left, normalized VIS CLI line intensity profiles of a 90Y source (Eppendorf, 55.5 MBq in 200 mL of saline) at increasing scattering tissue depths (chicken breast: 0, 10, and 15 mm). Full widths at half maximum increase with scattering tissue depth at 0, 10, and 15 mm with respective full widths at half maximum of 6.38, 13.05, and 33.64 mm. Right, representative VIS CLI images. (B) Left, normalized SWIR CLI line intensity profiles from the phantom setup with full widths at half maximums of 6.24, 6.40, and 7.04 mm. Right, representative SWIR CL images. In all cases, 3 separate line measurements are made from images at each depth (dotted lines), with mean shown (solid line). FWHM = full width at half maximum.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    In vitro and ex vivo SWIR CLI (900–1,700 nm) radioisotope sensitivity limit for 68Ga radiolabeled SiNPs. (A) SWIR CLI radioisotope in vitro detection limit for 68Ga-SiNPs after multiple half-lives. (B) SWIR CLI decay tracking to the limit of detection, linear regression (solid black line, R2 = 0.9882) and 95% CIs (solid gray lines) are shown. (C) Ex vivo SWIR CLI limit of detection for 68Ga-labeled SiNPs. The detection limit slightly worsens in tissue compared with in vitro imaging (∼140 kBq less sensitive). (D) Linear regression analysis (R2 = 0.9923) of ex vivo SWIR CLI of 68Ga-labeled SiNPs to limit of detection (403.3 kBq, C), 95% CIs are shown (solid gray lines). Detection limit paw is labeled with a white arrow.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    In vivo SWIR CLI detection of 90Y-labeled SiNPs 3 h after injection into footpad. (A, left) Representative image of mouse injected (+) with 90Y-labeled SiNPs (∼7.4 MBq). (A, right) Image of control mouse without any injection. (B) Quantified signal-to-background ratios of injected (n = 4) vs. control mice (n = 1). All images are shown in respective signal-to-background ratios. SBR = signal-to-background ratio.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (1)
Journal of Nuclear Medicine
Vol. 64, Issue 1
January 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes
Benedict E. Mc Larney, Qize Zhang, Edwin C. Pratt, Magdalena Skubal, Elizabeth Isaac, Hsiao-Ting Hsu, Anuja Ogirala, Jan Grimm
Journal of Nuclear Medicine Jan 2023, 64 (1) 177-182; DOI: 10.2967/jnumed.122.264079

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes
Benedict E. Mc Larney, Qize Zhang, Edwin C. Pratt, Magdalena Skubal, Elizabeth Isaac, Hsiao-Ting Hsu, Anuja Ogirala, Jan Grimm
Journal of Nuclear Medicine Jan 2023, 64 (1) 177-182; DOI: 10.2967/jnumed.122.264079
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study
  • [11C]ZTP-1: An Effective Short-Lived Radioligand for PET of Rat and Monkey Brain Phosphodiesterase Type 4 Subtype B
  • Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model
Show more Basic Science Investigation

Similar Articles

Keywords

  • SWIR
  • Cerenkov
  • luminescence
  • radioisotopes
  • preclinical
SNMMI

© 2025 SNMMI

Powered by HighWire